Logo image of CDRE

CADRE HOLDINGS INC (CDRE) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:CDRE - US12763L1052 - Common Stock

42.8 USD
-0.3 (-0.7%)
Last: 12/10/2025, 7:35:55 PM
42.8 USD
0 (0%)
After Hours: 12/10/2025, 7:35:55 PM
Fundamental Rating

6

CDRE gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 72 industry peers in the Aerospace & Defense industry. While CDRE belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CDRE is growing strongly while it is still valued neutral. This is a good combination! These ratings could make CDRE a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CDRE had positive earnings in the past year.
In the past year CDRE had a positive cash flow from operations.
Each year in the past 5 years CDRE has been profitable.
Each year in the past 5 years CDRE had a positive operating cash flow.
CDRE Yearly Net Income VS EBIT VS OCF VS FCFCDRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

CDRE has a better Return On Assets (5.73%) than 70.83% of its industry peers.
CDRE has a better Return On Equity (13.33%) than 79.17% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.65%, CDRE is in the better half of the industry, outperforming 73.61% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CDRE is in line with the industry average of 8.58%.
Industry RankSector Rank
ROA 5.73%
ROE 13.33%
ROIC 8.65%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
CDRE Yearly ROA, ROE, ROICCDRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300 400

1.3 Margins

Looking at the Profit Margin, with a value of 7.33%, CDRE is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CDRE has grown nicely.
Looking at the Operating Margin, with a value of 13.72%, CDRE belongs to the top of the industry, outperforming 80.56% of the companies in the same industry.
CDRE's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 42.68%, CDRE belongs to the top of the industry, outperforming 81.94% of the companies in the same industry.
CDRE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.72%
PM (TTM) 7.33%
GM 42.68%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
CDRE Yearly Profit, Operating, Gross MarginsCDRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

CDRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CDRE has been increased compared to 1 year ago.
The number of shares outstanding for CDRE has been increased compared to 5 years ago.
CDRE has a worse debt/assets ratio than last year.
CDRE Yearly Shares OutstandingCDRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CDRE Yearly Total Debt VS Total AssetsCDRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

CDRE has an Altman-Z score of 3.94. This indicates that CDRE is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.94, CDRE perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
The Debt to FCF ratio of CDRE is 5.12, which is a neutral value as it means it would take CDRE, 5.12 years of fcf income to pay off all of its debts.
CDRE has a better Debt to FCF ratio (5.12) than 70.83% of its industry peers.
A Debt/Equity ratio of 0.87 indicates that CDRE is somewhat dependend on debt financing.
CDRE's Debt to Equity ratio of 0.87 is on the low side compared to the rest of the industry. CDRE is outperformed by 72.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 5.12
Altman-Z 3.94
ROIC/WACC0.89
WACC9.72%
CDRE Yearly LT Debt VS Equity VS FCFCDRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 3.64 indicates that CDRE has no problem at all paying its short term obligations.
CDRE has a better Current ratio (3.64) than 75.00% of its industry peers.
CDRE has a Quick Ratio of 2.58. This indicates that CDRE is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.58, CDRE is doing good in the industry, outperforming 76.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.64
Quick Ratio 2.58
CDRE Yearly Current Assets VS Current LiabilitesCDRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.94% over the past year.
The Earnings Per Share has been growing by 34.28% on average over the past years. This is a very strong growth
Looking at the last year, CDRE shows a quite strong growth in Revenue. The Revenue has grown by 19.94% in the last year.
CDRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.17% yearly.
EPS 1Y (TTM)34.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%200%
Revenue 1Y (TTM)19.94%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%42.47%

3.2 Future

Based on estimates for the next years, CDRE will show a very strong growth in Earnings Per Share. The EPS will grow by 21.05% on average per year.
The Revenue is expected to grow by 10.39% on average over the next years. This is quite good.
EPS Next Y34.19%
EPS Next 2Y24.7%
EPS Next 3Y21.05%
EPS Next 5YN/A
Revenue Next Year11.31%
Revenue Next 2Y9.75%
Revenue Next 3Y8.29%
Revenue Next 5Y10.39%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDRE Yearly Revenue VS EstimatesCDRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M
CDRE Yearly EPS VS EstimatesCDRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

CDRE is valuated quite expensively with a Price/Earnings ratio of 38.21.
CDRE's Price/Earnings ratio is a bit cheaper when compared to the industry. CDRE is cheaper than 65.28% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.59, CDRE is valued a bit more expensive.
With a Price/Forward Earnings ratio of 30.58, CDRE can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CDRE is valued a bit cheaper than 68.06% of the companies in the same industry.
CDRE is valuated rather expensively when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.21
Fwd PE 30.58
CDRE Price Earnings VS Forward Price EarningsCDRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CDRE indicates a somewhat cheap valuation: CDRE is cheaper than 72.22% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CDRE is valued cheaper than 86.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.39
EV/EBITDA 18.61
CDRE Per share dataCDRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

CDRE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CDRE may justify a higher PE ratio.
CDRE's earnings are expected to grow with 21.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.12
PEG (5Y)N/A
EPS Next 2Y24.7%
EPS Next 3Y21.05%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.87%, CDRE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.12, CDRE pays a better dividend. On top of this CDRE pays more dividend than 84.72% of the companies listed in the same industry.
With a Dividend Yield of 0.87, CDRE pays less dividend than the S&P500 average, which is at 2.31.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

CDRE has been paying a dividend for over 5 years, so it has already some track record.
CDRE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years3
CDRE Yearly Dividends per shareCDRE Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

33.35% of the earnings are spent on dividend by CDRE. This is a low number and sustainable payout ratio.
DP33.35%
EPS Next 2Y24.7%
EPS Next 3Y21.05%
CDRE Yearly Income VS Free CF VS DividendCDRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 20M 40M 60M
CDRE Dividend Payout.CDRE Dividend Payout, showing the Payout Ratio.CDRE Dividend Payout.PayoutRetained Earnings

CADRE HOLDINGS INC

NYSE:CDRE (12/10/2025, 7:35:55 PM)

After market: 42.8 0 (0%)

42.8

-0.3 (-0.7%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)03-09 2026-03-09/amc
Inst Owners73.62%
Inst Owner Change4.34%
Ins Owners28.7%
Ins Owner Change-0.34%
Market Cap1.74B
Revenue(TTM)619.07M
Net Income(TTM)45.38M
Analysts78.46
Price Target49.47 (15.58%)
Short Float %6.91%
Short Ratio6.45
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.36
Dividend Growth(5Y)N/A
DP33.35%
Div Incr Years1
Div Non Decr Years3
Ex-Date10-31 2025-10-31 (0.095)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.55%
Min EPS beat(2)1.81%
Max EPS beat(2)11.29%
EPS beat(4)3
Avg EPS beat(4)17.3%
Min EPS beat(4)-31.8%
Max EPS beat(4)87.91%
EPS beat(8)6
Avg EPS beat(8)16.9%
EPS beat(12)9
Avg EPS beat(12)19.2%
EPS beat(16)10
Avg EPS beat(16)13.93%
Revenue beat(2)1
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)0.27%
Revenue beat(4)3
Avg Revenue beat(4)0.61%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)4.48%
Revenue beat(8)5
Avg Revenue beat(8)-0.89%
Revenue beat(12)8
Avg Revenue beat(12)0.27%
Revenue beat(16)11
Avg Revenue beat(16)0.47%
PT rev (1m)17.34%
PT rev (3m)25.97%
EPS NQ rev (1m)-5.92%
EPS NQ rev (3m)-8.84%
EPS NY rev (1m)-3.29%
EPS NY rev (3m)-2.95%
Revenue NQ rev (1m)0.54%
Revenue NQ rev (3m)1.05%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE 38.21
Fwd PE 30.58
P/S 2.81
P/FCF 28.39
P/OCF 26.3
P/B 5.11
P/tB 40.19
EV/EBITDA 18.61
EPS(TTM)1.12
EY2.62%
EPS(NY)1.4
Fwd EY3.27%
FCF(TTM)1.51
FCFY3.52%
OCF(TTM)1.63
OCFY3.8%
SpS15.23
BVpS8.37
TBVpS1.06
PEG (NY)1.12
PEG (5Y)N/A
Graham Number14.52
Profitability
Industry RankSector Rank
ROA 5.73%
ROE 13.33%
ROCE 12.38%
ROIC 8.65%
ROICexc 11.08%
ROICexgc 24.91%
OM 13.72%
PM (TTM) 7.33%
GM 42.68%
FCFM 9.9%
ROA(3y)5.33%
ROA(5y)6.73%
ROE(3y)11.56%
ROE(5y)96.32%
ROIC(3y)8.67%
ROIC(5y)11.97%
ROICexc(3y)11.24%
ROICexc(5y)14.1%
ROICexgc(3y)24.24%
ROICexgc(5y)30.41%
ROCE(3y)12.41%
ROCE(5y)17.14%
ROICexgc growth 3Y-11.18%
ROICexgc growth 5Y5.68%
ROICexc growth 3Y-14.82%
ROICexc growth 5Y2.49%
OM growth 3Y-0.25%
OM growth 5Y8.48%
PM growth 3Y28.91%
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5Y3.46%
F-Score6
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 5.12
Debt/EBITDA 2.89
Cap/Depr 27.05%
Cap/Sales 0.79%
Interest Coverage 5
Cash Conversion 64.27%
Profit Quality 135.07%
Current Ratio 3.64
Quick Ratio 2.58
Altman-Z 3.94
F-Score6
WACC9.72%
ROIC/WACC0.89
Cap/Depr(3y)35.32%
Cap/Depr(5y)31.71%
Cap/Sales(3y)1.12%
Cap/Sales(5y)1.04%
Profit Quality(3y)322.36%
Profit Quality(5y)273.24%
High Growth Momentum
Growth
EPS 1Y (TTM)34.94%
EPS 3Y34.28%
EPS 5YN/A
EPS Q2Q%200%
EPS Next Y34.19%
EPS Next 2Y24.7%
EPS Next 3Y21.05%
EPS Next 5YN/A
Revenue 1Y (TTM)19.94%
Revenue growth 3Y9.92%
Revenue growth 5Y6.17%
Sales Q2Q%42.47%
Revenue Next Year11.31%
Revenue Next 2Y9.75%
Revenue Next 3Y8.29%
Revenue Next 5Y10.39%
EBIT growth 1Y55.24%
EBIT growth 3Y9.65%
EBIT growth 5Y15.18%
EBIT Next Year72.67%
EBIT Next 3Y28.67%
EBIT Next 5Y27.66%
FCF growth 1Y6.85%
FCF growth 3Y-11.18%
FCF growth 5Y43.24%
OCF growth 1Y4.74%
OCF growth 3Y-7.45%
OCF growth 5Y33.8%

CADRE HOLDINGS INC / CDRE FAQ

Can you provide the ChartMill fundamental rating for CADRE HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to CDRE.


Can you provide the valuation status for CADRE HOLDINGS INC?

ChartMill assigns a valuation rating of 5 / 10 to CADRE HOLDINGS INC (CDRE). This can be considered as Fairly Valued.


Can you provide the profitability details for CADRE HOLDINGS INC?

CADRE HOLDINGS INC (CDRE) has a profitability rating of 8 / 10.


What is the valuation of CADRE HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CADRE HOLDINGS INC (CDRE) is 38.21 and the Price/Book (PB) ratio is 5.11.


What is the financial health of CADRE HOLDINGS INC (CDRE) stock?

The financial health rating of CADRE HOLDINGS INC (CDRE) is 5 / 10.